BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 24189076)

  • 1. Electricians' chrysotile asbestos exposure from electrical products and risks of mesothelioma and lung cancer.
    Goodman JE; Peterson MK; Bailey LA; Kerper LE; Dodge DG
    Regul Toxicol Pharmacol; 2014 Feb; 68(1):8-15. PubMed ID: 24189076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():49-73. PubMed ID: 18686078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of tremolite asbestos exposures associated with the use of commercial products.
    Finley BL; Pierce JS; Phelka AD; Adams RE; Paustenbach DJ; Thuett KA; Barlow CA
    Crit Rev Toxicol; 2012 Feb; 42(2):119-46. PubMed ID: 22141364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of reported no-effect chrysotile asbestos exposures for lung cancer and mesothelioma.
    Pierce JS; McKinley MA; Paustenbach DJ; Finley BL
    Crit Rev Toxicol; 2008; 38(3):191-214. PubMed ID: 18324516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chrysotile asbestos is the main cause of pleural mesothelioma.
    Smith AH; Wright CC
    Am J Ind Med; 1996 Sep; 30(3):252-66. PubMed ID: 8876792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An updated evaluation of reported no-observed adverse effect levels for chrysotile, amosite, and crocidolite asbestos for lung cancer and mesothelioma.
    Beckett EM; Abelmann A; Roberts B; Lewis RC; Cheatham D; Miller EW; Hall E; Pierce JS
    Crit Rev Toxicol; 2023 Nov; 53(10):611-657. PubMed ID: 38126124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Asbestos exposure and related diseases among friction products workers (1971-2016)].
    Barbieri PG; Mirabelli D; Madeo E; Somigliana A
    G Ital Med Lav Ergon; 2020 Sep; 42(3):145-152. PubMed ID: 33119974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure.
    Hodgson JT; Darnton A
    Ann Occup Hyg; 2000 Dec; 44(8):565-601. PubMed ID: 11108782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case control study of lung cancer and exposure to chrysotile and amphibole at a slovenian asbestos-cement plant.
    Dodic Fikfak M; Kriebel D; Quinn MM; Eisen EA; Wegman DH
    Ann Occup Hyg; 2007 Apr; 51(3):261-8. PubMed ID: 17351264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of mesothelioma from exposure to chrysotile asbestos.
    Yarborough CM
    Curr Opin Pulm Med; 2007 Jul; 13(4):334-8. PubMed ID: 17534182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The health risk of chrysotile asbestos.
    Bernstein DM
    Curr Opin Pulm Med; 2014 Jul; 20(4):366-70. PubMed ID: 24811832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occupational exposure to chrysotile asbestos and cancer risk: a review of the amphibole hypothesis.
    Stayner LT; Dankovic DA; Lemen RA
    Am J Public Health; 1996 Feb; 86(2):179-86. PubMed ID: 8633733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality from occupational exposure to relatively pure chrysotile: a 39-year study.
    Sichletidis L; Chloros D; Spyratos D; Haidich AB; Fourkiotou I; Kakoura M; Patakas D
    Respiration; 2009; 78(1):63-8. PubMed ID: 18843176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The health effects of chrysotile: current perspective based upon recent data.
    Bernstein DM; Hoskins JA
    Regul Toxicol Pharmacol; 2006 Aug; 45(3):252-64. PubMed ID: 16814911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical review of the 2020 EPA risk assessment for chrysotile and its many shortcomings.
    Paustenbach D; Brew D; Ligas S; Heywood J
    Crit Rev Toxicol; 2021 Jul; 51(6):509-539. PubMed ID: 34651555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment of mesothelioma and lung cancer risk based on Phase Contrast Microscopy (PCM) estimates of fibre exposure: an update of 2000 asbestos cohort data.
    Darnton L
    Environ Res; 2023 Aug; 230():114753. PubMed ID: 36965802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonoccupational exposure to chrysotile asbestos and the risk of lung cancer.
    Churg A
    N Engl J Med; 1998 Oct; 339(14):999; author reply 1001-2. PubMed ID: 9766991
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent data on cancer due to asbestos in the U.S.A. and Denmark.
    Nicholson WJ; Raffn E
    Med Lav; 1995; 86(5):393-410. PubMed ID: 8684290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragments.
    Gamble JF; Gibbs GW
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S154-86. PubMed ID: 18396365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.